RE: 11th Jun 202012 Feb 2025 16:51
Of course not Peter, that would be unnecessary and you know you are being silly. This first patient is very significant, they are the first one in the trial that has been coming after literally years of research and hard work. there is a lot of anticipation involved. It would be a very unlikely event for one after another in a line to have an initial suitability assessment and then get excluded one after another, and you know it.
It’s obvious to everyone what you are doing when you turn up here and if it’s not I’ll make it very clear. You don’t have any shares, you are very tempted but you would like the price to go lower before you buy. Either that or you have an open short and you dread good news at 0700 each day.
PeterP***k would be more apt for you.